Author:
Pontiroli A. E.,Fattor B.,Pozza G.,Pianezzola E.,Benedetti M. Strolin,Musatti L.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference15 articles.
1. Fuccella LM, Goldaniga G, Lovisolo P, Moggi E, Musatti L, Mandelli V, Sirtori CR (1980) Inhibition of lipolysis by nicotinic acid and by acipimox. Clin Pharmacol Ther 28: 790–795
2. Sommariva D, Pogliaghi I, Bonfiglioli D, Cabrine C, Tirrito M, Lavezzari M (1985) Changes in lipoprotein cholesterol and tryglicerides induced by acipimox in type IV and type III hyperlipoproteinaemic patients. Curr Ther Res 37: 363–368
3. Stuyt PMJ, Stalenhoef AFM, Demacker PNM, Van't Laar A (1985) A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia. Atherosclerosis 55: 51–62
4. Taskinen MR, Nikkila EA (1988) Effects of acipimox on serum lipids, lipoproteins and lipolitic enzymes in hypertriglyceridemia. Atherosclerosis 69: 249–255
5. Crepaldi G, Avogaro P, Descovich GC, Di Pietri T, Postiglione A, Sirtori CR, Strano A, Ventura S, Musatti L (1988) Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia. Atherosclerosis 70: 115–121
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献